Development and Pharmacokinetic Evaluation of Two Parenteral Formulations of Albendazole Using Prodrug and Cosolvent Approaches
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Development and Pharmacokinetic Evaluation of Two Parenteral Formulations of Albendazole Using Prodrug and Cosolvent Approaches ; volume:24 ; number:6 ; day:27 ; month:7 ; year:2023 ; pages:1-10 ; date:8.2023
AAPS PharmSciTech / American Association of Pharmaceutical Scientists ; 24, Heft 6 (27.7.2023), 1-10, 8.2023
- Urheber
-
Becerril-Vega, José
Hernández-Campos, Alicia
González-Hernández, Iliana
Flores-Ramos, Miguel
Castillo, Rafael
Leyva-Gómez, Gerardo
Mayet-Cruz, Lourdes
Jung-Cook, Helgi
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1208/s12249-023-02613-9
- URN
-
urn:nbn:de:101:1-2023110608453579090247
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Becerril-Vega, José
- Hernández-Campos, Alicia
- González-Hernández, Iliana
- Flores-Ramos, Miguel
- Castillo, Rafael
- Leyva-Gómez, Gerardo
- Mayet-Cruz, Lourdes
- Jung-Cook, Helgi
- SpringerLink (Online service)
Ähnliche Objekte (12)
Standardised neonatal parenteral nutrition formulations – Australasian neonatal parenteral nutrition consensus update 2017
Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Standardised neonatal parenteral nutrition formulations – an Australasian group consensus 2012
Pharmacokinetic and Safety Study of Bismuth Potassium Citrate Formulations in Healthy Subjects
A Novel Prodrug of a nNOS Inhibitor with Improved Pharmacokinetic Potential
A Novel Prodrug of a nNOS Inhibitor with Improved Pharmacokinetic Potential
Lyso-phosphatidylcholine as an interfacial stabilizer for parenteral monoclonal antibody formulations
Safety and pharmacokinetic properties of a new formulation of parenteral artesunate in healthy Thai volunteers
Pharmacokinetic Bioequivalence of Two Inhaled Tiotropium Bromide Formulations in Healthy Volunteers
Fatty acid-modified poly(glycerol adipate) as a versatile matrix for parenteral depot formulations
Novel glycosyl prodrug of RXP03 as MMP-11 prodrug: design, synthesis and virtual screening
Standardised neonatal parenteral nutrition formulations – Australasian neonatal parenteral nutrition consensus update 2017
Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Standardised neonatal parenteral nutrition formulations – an Australasian group consensus 2012
Pharmacokinetic and Safety Study of Bismuth Potassium Citrate Formulations in Healthy Subjects
A Novel Prodrug of a nNOS Inhibitor with Improved Pharmacokinetic Potential
A Novel Prodrug of a nNOS Inhibitor with Improved Pharmacokinetic Potential
Lyso-phosphatidylcholine as an interfacial stabilizer for parenteral monoclonal antibody formulations
Safety and pharmacokinetic properties of a new formulation of parenteral artesunate in healthy Thai volunteers
Pharmacokinetic Bioequivalence of Two Inhaled Tiotropium Bromide Formulations in Healthy Volunteers
Fatty acid-modified poly(glycerol adipate) as a versatile matrix for parenteral depot formulations
Novel glycosyl prodrug of RXP03 as MMP-11 prodrug: design, synthesis and virtual screening
Standardised neonatal parenteral nutrition formulations – Australasian neonatal parenteral nutrition consensus update 2017
Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Standardised neonatal parenteral nutrition formulations – an Australasian group consensus 2012
Pharmacokinetic and Safety Study of Bismuth Potassium Citrate Formulations in Healthy Subjects
A Novel Prodrug of a nNOS Inhibitor with Improved Pharmacokinetic Potential
A Novel Prodrug of a nNOS Inhibitor with Improved Pharmacokinetic Potential
Lyso-phosphatidylcholine as an interfacial stabilizer for parenteral monoclonal antibody formulations
Safety and pharmacokinetic properties of a new formulation of parenteral artesunate in healthy Thai volunteers
Pharmacokinetic Bioequivalence of Two Inhaled Tiotropium Bromide Formulations in Healthy Volunteers
Fatty acid-modified poly(glycerol adipate) as a versatile matrix for parenteral depot formulations